[Optimized Detection and Characterization of Liver Metastases : The Role of Current MRI Contrast Agents]

Overview

Journal Radiologe

Specialty Radiology

Date 2017 Feb 17

PMID 28204853

Authors

J M Weinrich

L Well

P Bannas

Affiliations

Soon will be listed here.

Abstract

Metastases are the most common malignant lesions of the liver. The presence of liver metastases is an important prognostic factor and is decisive for the further management, especially in patients with colorectal cancer. Detection and characterization of liver metastases as well as differentiation from benign lesions are of high importance and a daily challenge in clinical radiology. Contrast-enhanced magnetic resonance imaging (MRI) has the highest sensitivity in detecting liver metastases. The sensitivity of MRI has been further increased due to the development of liver-specific contrast agents. This article describes the role of extracellular and hepatobiliary contrast agents for the detection and characterization of liver metastases. Moreover, the current knowledge on safety, sequence optimization, transient severe dyspnea and the combination of hepatobiliary with intravascular contrast agents for liver imaging is discussed.

References

Zech C, Herrmann K, Reiser M, Schoenberg S . MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci. 2007; 6(1):43-52. DOI: 10.2463/mrms.6.43. View

Zech C, Justo N, Lang A, Ba-Ssalamah A, Kim M, Rinde H . Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial. Eur Radiol. 2016; 26(11):4121-4130. PMC: 5052297. DOI: 10.1007/s00330-016-4271-0. View

Kim H, Lee S, Byun J, Kim J, Yu C, Park S . Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR.... Radiology. 2014; 274(3):712-22. DOI: 10.1148/radiol.14140390. View

Motosugi U, Bannas P, Bookwalter C, Sano K, Reeder S . An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology. 2015; 279(1):93-102. PMC: 5562163. DOI: 10.1148/radiol.2015150642. View

Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W . Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. Radiology. 2010; 256(3):817-26. DOI: 10.1148/radiol.10092214. View

Hayashi T, Saitoh S, Tsuji Y, Takahashi J, Tagaya N, Hiramoto M . Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging. Radiology. 2015; 276(3):756-65. DOI: 10.1148/radiol.2015141646. View

Zech C, Korpraphong P, Huppertz A, Denecke T, Kim M, Tanomkiat W . Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014; 101(6):613-21. PMC: 4312911. DOI: 10.1002/bjs.9465. View

Thomsen H, Morcos S, Almen T, Bellin M, Bertolotto M, Bongartz G . Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2012; 23(2):307-18. DOI: 10.1007/s00330-012-2597-9. View

Cruite I, Schroeder M, Merkle E, Sirlin C . Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol. 2010; 195(1):29-41. DOI: 10.2214/AJR.10.4538. View

10.

Radbruch A, Weberling L, Kieslich P, Eidel O, Burth S, Kickingereder P . Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015; 275(3):783-91. DOI: 10.1148/radiol.2015150337. View

11.

Grobner T . Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant. 2006; 21(4):1104-8. DOI: 10.1093/ndt/gfk062. View

12.

Radbruch A, Haase R, Kieslich P, Weberling L, Kickingereder P, Wick W . No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents. Radiology. 2016; 282(3):699-707. DOI: 10.1148/radiol.2016162241. View

13.

Fowler K, Linehan D, Menias C . Colorectal liver metastases: state of the art imaging. Ann Surg Oncol. 2012; 20(4):1185-93. DOI: 10.1245/s10434-012-2730-7. View

14.

Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G . Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 2003; 230(1):266-75. DOI: 10.1148/radiol.2301020269. View

15.

Reeder S, Gulani V . Gadolinium Deposition in the Brain: Do We Know Enough to Change Practice?. Radiology. 2016; 279(1):323-6. DOI: 10.1148/radiol.2016151372. View

16.

Errante Y, Cirimele V, Mallio C, Di Lazzaro V, Zobel B, Cosimo Quattrocchi C . Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol. 2014; 49(10):685-90. DOI: 10.1097/RLI.0000000000000072. View

17.

Imam K, Bluemke D . MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin N Am. 2001; 8(4):741-56. View

18.

Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K . Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging. 2011; 34(2):326-35. DOI: 10.1002/jmri.22613. View

19.

Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K . Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology. 2011; 260(2):446-53. DOI: 10.1148/radiol.11103548. View

20.

Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann H . Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol. 2008; 43(12):817-28. DOI: 10.1097/RLI.0b013e3181852171. View